{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:14:58Z","timestamp":1792818898129,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41380-024-02863-4","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T02:23:39Z","timestamp":1733365419000},"page":"1676-1688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-3845","authenticated-orcid":false,"given":"Jonathan M.","family":"Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Haebich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-3495","authenticated-orcid":false,"given":"Rebecca","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-2813","authenticated-orcid":false,"given":"Kiymet","family":"Bozaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Giliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2531-8413","authenticated-orcid":false,"given":"Paul J.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-0932","authenticated-orcid":false,"given":"Silvia","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-1435","authenticated-orcid":false,"given":"Gareth","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn N.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2863_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","volume":"20","author":"J Stiles","year":"2010","unstructured":"Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev. 2010;20:327\u201348.","journal-title":"Neuropsychol Rev"},{"key":"2863_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.siny.2006.07.001","volume":"11","author":"I Kostovi\u0107","year":"2006","unstructured":"Kostovi\u0107 I, Jovanov-Milosevi\u0107 N. The development of cerebral connections during the first 20-45 weeks\u2019 gestation. Semin Fetal Neonatal Med. 2006;11:415\u201322.","journal-title":"Semin Fetal Neonatal Med"},{"key":"2863_CR3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1203\/00006450-200012000-00004","volume":"48","author":"P Gressens","year":"2000","unstructured":"Gressens P. Mechanisms and disturbances of neuronal migration. Pediatr Res. 2000;48:725\u201330.","journal-title":"Pediatr Res"},{"key":"2863_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.devcel.2015.01.035","volume":"32","author":"BI Bae","year":"2015","unstructured":"Bae BI, Jayaraman D, Walsh CA. Genetic changes shaping the human brain. Dev Cell. 2015;32:423\u201334.","journal-title":"Dev Cell"},{"key":"2863_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00921-3","volume":"10","author":"S Hashem","year":"2020","unstructured":"Hashem S, Nisar S, Bhat AA, Yadav SK, Azeem MW, Bagga P, et al. Genetics of structural and functional brain changes in autism spectrum disorder. Transl Psychiatry. 2020;10:229.","journal-title":"Transl Psychiatry"},{"key":"2863_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","volume":"1380","author":"C Betancur","year":"2011","unstructured":"Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011;1380:42\u201377.","journal-title":"Brain Res"},{"key":"2863_CR7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/jpc.14202","volume":"54","author":"DJ Amor","year":"2018","unstructured":"Amor DJ. Investigating the child with intellectual disability. J Paediatr Child Health. 2018;54:1154\u20138.","journal-title":"J Paediatr Child Health"},{"key":"2863_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","volume":"37","author":"K Inoki","year":"2005","unstructured":"Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2005;37:19\u201324.","journal-title":"Nat Genet"},{"key":"2863_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/npp.2011.185","volume":"37","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacol. 2012;37:196\u2013212.","journal-title":"Neuropsychopharmacol"},{"key":"2863_CR10","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589.","journal-title":"J Cell Sci"},{"key":"2863_CR11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"2863_CR12","doi-asserted-by":"crossref","unstructured":"Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci. 2014;7:28.","DOI":"10.3389\/fnmol.2014.00028"},{"key":"2863_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","volume":"341","author":"K Switon","year":"2017","unstructured":"Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Molecular neurobiology of mTOR. Neurosci. 2017;341:112\u201353.","journal-title":"Neurosci"},{"key":"2863_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275\u201391.","journal-title":"Neuron"},{"key":"2863_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","volume":"24","author":"DY Lee","year":"2015","unstructured":"Lee DY. Roles of mTOR signaling in brain development. Exp Neurobiol. 2015;24:177\u201385.","journal-title":"Exp Neurobiol"},{"key":"2863_CR16","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","volume":"102","author":"CM Johannessen","year":"2005","unstructured":"Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Nat Acad Sci USA. 2005;102:8573\u20138.","journal-title":"Proc Nat Acad Sci USA"},{"key":"2863_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","volume":"11","author":"JA Hobert","year":"2009","unstructured":"Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009;11:687\u201394.","journal-title":"Genet Med"},{"key":"2863_CR18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/leu.2016.326","volume":"31","author":"W Liu","year":"2017","unstructured":"Liu W, Yu WM, Zhang J, Chan RJ, Loh ML, Zhang Z, et al. Inhibition of the Gab2\/PI3K\/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations. Leukemia. 2017;31:1415\u201322.","journal-title":"Leukemia"},{"key":"2863_CR19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010;30:694\u2013702.","journal-title":"J Neurosci"},{"key":"2863_CR20","doi-asserted-by":"crossref","DOI":"10.1186\/2040-2392-3-5","volume":"3","author":"P Chaste","year":"2012","unstructured":"Chaste P, Betancur C, G\u00e9rard-Blanluet M, Bargiacchi A, Kuzbari S, Drunat S, et al. High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters. Mol Autism. 2012;3:5.","journal-title":"Mol Autism"},{"key":"2863_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11065-018-9380-x","volume":"28","author":"AK Chisholm","year":"2018","unstructured":"Chisholm AK, Anderson V, Pride NA, Malarbi S, North KN, Payne JM. Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28:317\u201340.","journal-title":"Neuropsychol Rev"},{"key":"2863_CR22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356.","journal-title":"N Engl J Med"},{"key":"2863_CR23","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1073\/pnas.1620994114","volume":"114","author":"JL Bruno","year":"2017","unstructured":"Bruno JL, Romano D, Mazaika P, Lightbody AA, Hazlett HC, Piven J, et al. Longitudinal identification of clinically distinct neurophenotypes in young children with fragile X syndrome. Proc Natl Acad Sci USA. 2017;114:10767\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2863_CR24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/dmcn.13394","volume":"59","author":"S Garg","year":"2017","unstructured":"Garg S, Brooks A, Burns A, Burkitt-Wright E, Kerr B, Huson S, et al. Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras\/MAPK pathway. Dev Med Child Neurol. 2017;59:544\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"2863_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jmedgenet-2016-104484","volume":"54","author":"E Hansen-Kiss","year":"2017","unstructured":"Hansen-Kiss E, Beinkampen S, Adler B, Frazier T, Prior T, Erdman S, et al. A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children. J Med Genet. 2017;54:471\u20138.","journal-title":"J Med Genet"},{"key":"2863_CR26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/1087054719894384","volume":"25","author":"JM Payne","year":"2021","unstructured":"Payne JM, Haebich KH, MacKenzie R, Walsh KS, Hearps SJC, Coghill D, et al. Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1. J Atten Disord. 2021;25:1177\u201386.","journal-title":"J Atten Disord"},{"key":"2863_CR27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1177\/0883073809341272","volume":"24","author":"E D\u2019Agati","year":"2009","unstructured":"D\u2019Agati E, Moavero R, Cerminara C, Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol. 2009;24:1282\u20137.","journal-title":"J Child Neurol"},{"key":"2863_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jir.12226","volume":"60","author":"M Grefer","year":"2016","unstructured":"Grefer M, Flory K, Cornish K, Hatton D, Roberts J. The emergence and stability of attention deficit hyperactivity disorder in boys with fragile X syndrome. J Iintellect Disabil Res. 2016;60:167\u201378.","journal-title":"J Iintellect Disabil Res"},{"key":"2863_CR29","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/acn3.50952","volume":"6","author":"JM Payne","year":"2019","unstructured":"Payne JM, Hearps SJC, Walsh KS, Paltin I, Barton B, Ullrich NJ, et al. Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol. 2019;6:2555\u201365.","journal-title":"Ann Clin Transl Neurol"},{"key":"2863_CR30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ejhg.2011.241","volume":"20","author":"AM van Eeghen","year":"2012","unstructured":"van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA. Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet. 2012;20:510\u20135.","journal-title":"Eur J Hum Genet"},{"key":"2863_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiol Dis. 2020;136:104740.","journal-title":"Neurobiol Dis"},{"key":"2863_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-018-0477-x","volume":"44","author":"C Santoro","year":"2018","unstructured":"Santoro C, Bernardo P, Coppola A, Pugliese U, Cirillo M, Giugliano T, et al. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough? Ital J Pediatr. 2018;44:41.","journal-title":"Ital J Pediatr"},{"key":"2863_CR33","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1523\/JNEUROSCI.2260-18.2019","volume":"39","author":"LH Nguyen","year":"2019","unstructured":"Nguyen LH, Mahadeo T, Bordey A. mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J Neurosci. 2019;39:2762.","journal-title":"J Neurosci"},{"key":"2863_CR34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jnnp.2009.179630","volume":"81","author":"JM Payne","year":"2010","unstructured":"Payne JM, Moharir MD, Webster R, North KN. Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry. 2010;81:304\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2863_CR35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ajmg.1320600603","volume":"60","author":"MB Schapiro","year":"1995","unstructured":"Schapiro MB, Murphy DG, Hagerman RJ, Azari NP, Alexander GE, Miezejeski CM, et al. Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism. Am J Med Genet. 1995;60:480\u201393.","journal-title":"Am J Med Genet"},{"key":"2863_CR36","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"2863_CR37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaac.2012.07.003","volume":"51","author":"HC Hazlett","year":"2012","unstructured":"Hazlett HC, Poe MD, Lightbody AA, Styner M, MacFall JR, Reiss AL, et al. Trajectories of early brain volume development in fragile X syndrome and autism. J Am Acad Child Adolesc Psychiatry. 2012;51:921\u201333.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2863_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV. Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Ed Stat. 1981;6:107\u201328.","journal-title":"J Ed Stat"},{"key":"2863_CR39","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum; 1988."},{"key":"2863_CR40","doi-asserted-by":"crossref","unstructured":"Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons; 2009.","DOI":"10.1002\/9780470743386"},{"key":"2863_CR41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and Fill: A simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"2863_CR42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"2863_CR43","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013, https:\/\/www.ohri.ca\/\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2863_CR44","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"2863_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/088307380001500303","volume":"15","author":"LE Cutting","year":"2000","unstructured":"Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol. 2000;15:157\u201360.","journal-title":"J Child Neurol"},{"key":"2863_CR46","first-page":"146","volume":"9","author":"M Siqueiros-Sanchez","year":"2024","unstructured":"Siqueiros-Sanchez M, Rai B, Chowdhury S, Reiss AL, Green T. Syndrome-specific neuroanatomical phenotypes in girls With Turner and Noonan syndromes. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9:146\u201355.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2863_CR47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pscychresns.2009.04.013","volume":"174","author":"LB Wilson","year":"2009","unstructured":"Wilson LB, Tregellas JR, Hagerman RJ, Rogers SJ, Rojas DC. A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism. Psychiatry Res. 2009;174:138\u201345.","journal-title":"Psychiatry Res"},{"key":"2863_CR48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hbm.22161","volume":"35","author":"JV Duarte","year":"2014","unstructured":"Duarte JV, Ribeiro MJ, Violante IR, Cunha G, Silva E, Castelo-Branco M. Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1. Hum Brain Mapp. 2014;35:89\u2013106.","journal-title":"Hum Brain Mapp"},{"key":"2863_CR49","first-page":"2310","volume":"32","author":"CH Lee","year":"2021","unstructured":"Lee CH, Bartholomay KL, Marzelli MJ, Miller JG, Bruno JL, Lightbody AA, et al. Neuroanatomical profile of young females with Fragile X syndrome: a voxel-based morphometry analysis. Cereb Cortex. 2021;32:2310\u201320.","journal-title":"Cereb Cortex"},{"key":"2863_CR50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/radiol.2018172863","volume":"289","author":"MJ Barkovich","year":"2018","unstructured":"Barkovich MJ, Tan CH, Nillo RM, Li Y, Xu D, Glastonbury CM, et al. Abnormal morphology of select cortical and subcortical regions in neurofibromatosis type 1. Radiology. 2018;289:499\u2013508.","journal-title":"Radiology"},{"key":"2863_CR51","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/archneur.62.12.1904","volume":"62","author":"RS Greenwood","year":"2005","unstructured":"Greenwood RS, Tupler LA, Whitt JK, Buu A, Dombeck CB, Harp AG, et al. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Arch Neurol. 2005;62:1904\u20138.","journal-title":"Arch Neurol"},{"key":"2863_CR52","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/00001756-199608120-00015","volume":"7","author":"SM Said","year":"1996","unstructured":"Said SM, Yeh TL, Greenwood RS, Whitt JK, Tupler LA, Krishnan KR. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport. 1996;7:1941\u20134.","journal-title":"Neuroreport"},{"key":"2863_CR53","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/brain\/124.8.1610","volume":"124","author":"S Eliez","year":"2001","unstructured":"Eliez S, Blasey CM, Freund LS, Hastie T, Reiss AL. Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain. 2001;124:1610\u20138.","journal-title":"Brain"},{"key":"2863_CR54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroimage.2010.08.015","volume":"54","author":"BP Hallahan","year":"2011","unstructured":"Hallahan BP, Craig MC, Toal F, Daly EM, Moore CJ, Ambikapathy A, et al. In vivo brain anatomy of adult males with Fragile X syndrome: an MRI study. Neuroimage. 2011;54:16\u201324.","journal-title":"Neuroimage"},{"key":"2863_CR55","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/hbm.22334","volume":"35","author":"NA Pride","year":"2014","unstructured":"Pride NA, Korgaonkar MS, Barton B, Payne JM, Vucic S, North KN. The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1. Hum Brain Mapp. 2014;35:2372\u201382.","journal-title":"Hum Brain Mapp"},{"key":"2863_CR56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11689-015-9128-3","volume":"7","author":"S Huijbregts","year":"2015","unstructured":"Huijbregts S, Loitfelder M, Rombouts SA, Swaab H, Verbist BM, Arkink EB, et al. Cerebral volumetric abnormalities in neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms. J Neurodev Disord. 2015;7:32.","journal-title":"J Neurodev Disord"},{"key":"2863_CR57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","volume":"43","author":"I Parenti","year":"2020","unstructured":"Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 2020;43:608\u201321.","journal-title":"Trends Neurosci"},{"key":"2863_CR58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00213-013-3334-z","volume":"231","author":"JAS Vorstman","year":"2014","unstructured":"Vorstman JAS, Spooren W, Persico AM, Collier DA, Aigner S, Jagasia R, et al. Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacol. 2014;231:1063\u201378.","journal-title":"Psychopharmacol"},{"key":"2863_CR59","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ebiom.2015.09.013","volume":"2","author":"JM Payne","year":"2015","unstructured":"Payne JM. Bridging the gap between mouse behavior and human cognition in neurofibromatosis type 1. EBioMedicine. 2015;2:1290\u20131.","journal-title":"EBioMedicine"},{"key":"2863_CR60","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-021-00481-3","volume":"13","author":"AK Chisholm","year":"2022","unstructured":"Chisholm AK, Haebich KM, Pride NA, Walsh KS, Lami F, Ure A, et al. Delineating the autistic phenotype in children with neurofibromatosis type 1. Mol Autism. 2022;13:3.","journal-title":"Mol Autism"},{"key":"2863_CR61","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","volume":"139","author":"WE Kaufmann","year":"2017","unstructured":"Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, et al. Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment. Pediatrics. 2017;139:S194\u2013S206.","journal-title":"Pediatrics"},{"key":"2863_CR62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/dmcn.14787","volume":"63","author":"RA Mitchell","year":"2021","unstructured":"Mitchell RA, Barton SM, Harvey AS, Ure AM, Williams K. Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta-analysis. Dev Med Child Neurol. 2021;63:791\u2013801.","journal-title":"Dev Med Child Neurol"},{"key":"2863_CR63","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S0033291701004561","volume":"31","author":"K Ridler","year":"2001","unstructured":"Ridler K, Bullmore ET, De Vries PJ, Suckling J, Barker GJ, Meara SJ, et al. Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med. 2001;31:1437\u201346.","journal-title":"Psychol Med"},{"key":"2863_CR64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cercor\/bhj144","volume":"17","author":"K Ridler","year":"2007","unstructured":"Ridler K, Suckling J, Higgins NJ, de Vries PJ, Stephenson CM, Bolton PF, et al. Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex. 2007;17:261\u201371.","journal-title":"Cereb Cortex"},{"key":"2863_CR65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/dmcn.14356","volume":"62","author":"C Tye","year":"2020","unstructured":"Tye C, McEwen FS, Liang H, Underwood L, Woodhouse E, Barker ED, et al. Long-term cognitive outcomes in tuberous sclerosis complex. Dev Med Child Neurol. 2020;62:322\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"2863_CR66","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/cercor\/bhy158","volume":"29","author":"EM Johnson","year":"2019","unstructured":"Johnson EM, Ishak AD, Naylor PE, Stevenson DA, Reiss AL, Green T. PTPN11 gain-of-function mutations affect the developing human brain, memory, and attention. Cereb Cortex. 2019;29:2915\u201323.","journal-title":"Cereb Cortex"},{"key":"2863_CR67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2007.03.027","volume":"54","author":"AS Gauthier","year":"2007","unstructured":"Gauthier AS, Furstoss O, Araki T, Chan R, Neel BG, Kaplan DR, et al. Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron. 2007;54:245\u201362.","journal-title":"Neuron"},{"key":"2863_CR68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/brainsci9010011","volume":"9","author":"KL Bartholomay","year":"2019","unstructured":"Bartholomay KL, Lee CH, Bruno JL, Lightbody AA, Reiss AL. Closing the gender gap in fragile X syndrome: review on females with FXS and preliminary research findings. Brain Sci. 2019;9:11.","journal-title":"Brain Sci"},{"key":"2863_CR69","doi-asserted-by":"crossref","unstructured":"Anastasaki C, Orozco P, Gutmann DH. RAS and beyond: the many faces of the neurofibromatosis type 1 protein. Dis Model Mech. 2022;15:dmm049362.","DOI":"10.1242\/dmm.049362"},{"key":"2863_CR70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","volume":"22","author":"JD Richter","year":"2021","unstructured":"Richter JD, Zhao X. The molecular biology of FMRP: new insights into fragile X syndrome. Nat Rev Neurosci. 2021;22:209\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"2863_CR71","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","volume":"15","author":"W Li","year":"2005","unstructured":"Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol. 2005;15:1961\u20137.","journal-title":"Curr Biol"},{"key":"2863_CR72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","volume":"135","author":"Y Cui","year":"2008","unstructured":"Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell. 2008;135:549\u201360.","journal-title":"Cell"},{"key":"2863_CR73","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nn.3822","volume":"17","author":"AI Molosh","year":"2014","unstructured":"Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C, et al. Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nat Neurosci. 2014;17:1583\u201390.","journal-title":"Nat Neurosci"},{"key":"2863_CR74","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1093\/emboj\/17.15.4313","volume":"17","author":"K Scheffzek","year":"1998","unstructured":"Scheffzek K, Ahmadian MR, Wiesm\u00fcller L, Kabsch W, Stege P, Schmitz F, et al. Structural analysis of the GAP-related domain from neurofibromin and its implications. Embo J. 1998;17:4313\u201327.","journal-title":"Embo J"},{"key":"2863_CR75","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","volume":"403","author":"HF Guo","year":"2000","unstructured":"Guo HF, Tong J, Hannan F, Luo L, Zhong Y. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature. 2000;403:895\u20138.","journal-title":"Nature"},{"key":"2863_CR76","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","volume":"24","author":"C Anastasaki","year":"2015","unstructured":"Anastasaki C, Woo AS, Messiaen LM, Gutmann DH. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning. Hum Mol Genet. 2015;24:3518\u201328.","journal-title":"Hum Mol Genet"},{"key":"2863_CR77","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1093\/hmg\/ddu389","volume":"23","author":"C Anastasaki","year":"2014","unstructured":"Anastasaki C, Gutmann DH. Neuronal NF1\/RAS regulation of cyclic AMP requires atypical PKC activation. Hum Mol Genet. 2014;23:6712\u201321.","journal-title":"Hum Mol Genet"},{"key":"2863_CR78","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/mp.2015.48","volume":"20","author":"A Omrani","year":"2015","unstructured":"Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW, et al. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry. 2015;20:1311\u201321.","journal-title":"Mol Psychiatry"},{"key":"2863_CR79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/WNL.0000000000005000","volume":"90","author":"SM Morris","year":"2018","unstructured":"Morris SM, Gutmann DH. A genotype-phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1. Neurology. 2018;90:377\u20139.","journal-title":"Neurology"},{"key":"2863_CR80","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/hmg\/ddad107","volume":"32","author":"M Pigoni","year":"2023","unstructured":"Pigoni M, Uzquiano A, Paulsen B, Kedaigle AJ, Yang SM, Symvoulidis P, et al. Cell-type specific defects in PTEN-mutant cortical organoids converge on abnormal circuit activity. Hum Mol Genet. 2023;32:2773\u201386.","journal-title":"Hum Mol Genet"},{"key":"2863_CR81","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/stem.1698","volume":"32","author":"Y Li","year":"2014","unstructured":"Li Y, Zhao X. Concise review: fragile X proteins in stem cell maintenance and differentiation. Stem Cells. 2014;32:1724\u201333.","journal-title":"Stem Cells"},{"key":"2863_CR82","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2012.06.034","volume":"150","author":"Y Wang","year":"2012","unstructured":"Wang Y, Kim E, Wang X, Novitch BG, Yoshikawa K, Chang LS, et al. ERK inhibition rescues defects in fate specification of Nf1-deficient neural Ppogenitors and brain abnormalities. Cell. 2012;150:816\u201330.","journal-title":"Cell"},{"key":"2863_CR83","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58737","volume":"9","author":"MG Andrews","year":"2020","unstructured":"Andrews MG, Subramanian L, Kriegstein AR. mTOR signaling regulates the morphology and migration of outer radial glia in developing human cortex. eLife. 2020;9:e58737.","journal-title":"eLife"},{"key":"2863_CR84","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrn4001","volume":"16","author":"JD Richter","year":"2015","unstructured":"Richter JD, Bassell GJ, Klann E. Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci. 2015;16:595\u2013605.","journal-title":"Nat Rev Neurosci"},{"key":"2863_CR85","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1523\/JNEUROSCI.4693-04.2005","volume":"25","author":"B Dasgupta","year":"2005","unstructured":"Dasgupta B. Gutmann DH. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci. 2005;25:5584\u201394.","journal-title":"J Neurosci"},{"key":"2863_CR86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000353248","volume":"35","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Corbin JG, Levy RJ. Programmed cell death is impaired in the developing brain of FMR1 mutants. Dev Neurosci. 2013;35:347\u201358.","journal-title":"Dev Neurosci"},{"key":"2863_CR87","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1152\/physrev.00038.2014","volume":"95","author":"J Bockaert","year":"2015","unstructured":"Bockaert J, Marin P. mTOR in brain physiology and pathologies. Physiol Rev. 2015;95:1157\u201387.","journal-title":"Physiol Rev"},{"key":"2863_CR88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1440-169X.2009.01101.x","volume":"51","author":"Y Kosodo","year":"2009","unstructured":"Kosodo Y, Huttner WB. Basal process and cell divisions of neural progenitors in the developing brain. Dev Growth Differ. 2009;51:251\u201361.","journal-title":"Dev Growth Differ"},{"key":"2863_CR89","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1523\/JNEUROSCI.1840-12.2013","volume":"33","author":"CA Lafourcade","year":"2013","unstructured":"Lafourcade CA, Lin TV, Feliciano DM, Zhang L, Hsieh LS, Bordey A. Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons. J Neurosci. 2013;33:2419\u201331.","journal-title":"J Neurosci"},{"key":"2863_CR90","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/0883073809350723","volume":"25","author":"N Pride","year":"2010","unstructured":"Pride N, Payne JM, Webster R, Shores EA, Rae C, North KN. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1. J Child Neurol. 2010;25:834\u201341.","journal-title":"J Child Neurol"},{"key":"2863_CR91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","volume":"13","author":"D Nie","year":"2010","unstructured":"Nie D, Di Nardo A, Han JM, Baharanyi H, Kramvis I, Huynh T, et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci. 2010;13:163\u201372.","journal-title":"Nat Neurosci"},{"key":"2863_CR92","volume":"10","author":"M Piper","year":"2015","unstructured":"Piper M, Lee AC, van Horck FP, McNeilly H, Lu TB, Harris WA, et al. Differential requirement of F-actin and microtubule cytoskeleton in cue-induced local protein synthesis in axonal growth cones. Neural Dev. 2015;10:3.","journal-title":"Neural Dev"},{"key":"2863_CR93","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1101\/gad.1685008","volume":"22","author":"YJ Choi","year":"2008","unstructured":"Choi YJ, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22:2485\u201395.","journal-title":"Genes Dev"},{"key":"2863_CR94","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","volume":"25","author":"V Kumar","year":"2005","unstructured":"Kumar V, Zhang MZ, Swank MW, Kunz J, Wu GY. Regulation of dendritic morphogenesis by Ras\u2013PI3K\u2013Akt\u2013mTOR and Ras\u2013MAPK signaling pathways. J Neurosci. 2005;25:11288.","journal-title":"J Neurosci"},{"key":"2863_CR95","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf5546","volume":"375","author":"OL Eichm\u00fcller","year":"2022","unstructured":"Eichm\u00fcller OL, Corsini NS, V\u00e9rtesy \u00c1, Morassut I, Scholl T, Gruber VE, et al. Amplification of human interneuron progenitors promotes brain tumors and neurological defects. Science. 2022;375:eabf5546.","journal-title":"Science"},{"key":"2863_CR96","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41592-021-01344-8","volume":"19","author":"Z He","year":"2022","unstructured":"He Z, Maynard A, Jain A, Gerber T, Petri R, Lin HC, et al. Lineage recording in human cerebral organoids. Nat Methods. 2022;19:90\u20139.","journal-title":"Nat Methods"},{"key":"2863_CR97","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","volume":"24","author":"JD Blair","year":"2018","unstructured":"Blair JD, Hockemeyer D, Bateup HS. Genetically engineered human cortical spheroid models of tuberous sclerosis. Nature Med. 2018;24:1568\u201378.","journal-title":"Nature Med"},{"key":"2863_CR98","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-04358-6","volume":"602","author":"B Paulsen","year":"2022","unstructured":"Paulsen B, Velasco S, Kedaigle AJ, Pigoni M, Quadrato G, Deo A, et al. Autist genes converge on asynchronous development of shared neuron clases. Nature. 2022;602:268\u201373.","journal-title":"Nature"},{"key":"2863_CR99","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110615","volume":"39","author":"CE Villa","year":"2022","unstructured":"Villa CE, Cheroni C, Dotter CP, L\u00f3pez-T\u00f3bon A, Oliveira B, Sacco R, et al. CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories. Cell Rep. 2022;39:110615.","journal-title":"Cell Rep"},{"key":"2863_CR100","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1038\/s41380-021-01243-6","volume":"26","author":"J Urresti","year":"2021","unstructured":"Urresti J, Zhang P, Moran-Losada P, Yu NK, Negraes PD, Trujillo CA, et al. Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. 2021;26:7560\u201380.","journal-title":"Mol Psychiatry"},{"key":"2863_CR101","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1101\/gad.332494.119","volume":"34","author":"W Zhang","year":"2020","unstructured":"Zhang W, Ma L, Yang M, Shao Q, Xu J, Lu Z, et al. Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly\/autism phenotypes. Genes Dev. 2020;34:580\u201397.","journal-title":"Genes Dev"},{"key":"2863_CR102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/dneu.22816","volume":"81","author":"LT Dang","year":"2021","unstructured":"Dang LT, Vaid S, Lin G, Swaminathan P, Safran J, Loughman A, et al. STRADA-mutant human cortical organoids model megalencephaly and exhibit delayed neuronal differentiation. Dev Neurobiol. 2021;81:696\u2013709.","journal-title":"Dev Neurobiol"},{"key":"2863_CR103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2016.11.017","volume":"20","author":"Y Li","year":"2017","unstructured":"Li Y, Muffat J, Omer A, Bosch I, Lancaster MA, Sur M, et al. Induction of expansion and folding in human cerebral organoids. Cell Stem Cell. 2017;20:385\u201396.e3.","journal-title":"Cell Stem Cell"},{"key":"2863_CR104","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Primers. 2017;3:17065.","journal-title":"Nat Rev Dis Primers"},{"key":"2863_CR105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S0954579412001113","volume":"25","author":"K Cornish","year":"2013","unstructured":"Cornish K, Cole V, Longhi E, Karmiloff-Smith A, Scerif G. Mapping developmental trajectories of attention and working memory in fragile X syndrome: developmental freeze or developmental change? Dev Psychopathol. 2013;25:365\u201376.","journal-title":"Dev Psychopathol"},{"key":"2863_CR106","first-page":"161","volume":"15","author":"MA Summers","year":"2015","unstructured":"Summers MA, Quinlan KG, Payne JM, Little DG, North KN, Schindeler A. Skeletal muscle and motor deficits in Neurofibromatosis Type 1. J Musculoskelet Neuronal Interact. 2015;15:161\u201370.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2863_CR107","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","volume":"65","author":"SL Hyman","year":"2005","unstructured":"Hyman SL, Shores EA, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65:1037\u201344.","journal-title":"Neurology"},{"key":"2863_CR108","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1469-8749.2002.tb00780.x","volume":"44","author":"VF Mautner","year":"2002","unstructured":"Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol. 2002;44:164\u201370.","journal-title":"Dev Med Child Neurol"},{"key":"2863_CR109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/09297049.2010.542746","volume":"17","author":"JM Payne","year":"2011","unstructured":"Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol. 2011;17:313\u201329.","journal-title":"Child Neuropsychol"},{"key":"2863_CR110","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","volume":"132","author":"S Garg","year":"2013","unstructured":"Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013;132:e1642\u2013e8.","journal-title":"Pediatrics"},{"key":"2863_CR111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11689-017-9205-x","volume":"9","author":"T Green","year":"2017","unstructured":"Green T, Naylor PE, Davies W. Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies. J Neurodev Disord. 2017;9:25.","journal-title":"J Neurodev Disord"},{"key":"2863_CR112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2018.12.001","volume":"62","author":"C Ciaccio","year":"2019","unstructured":"Ciaccio C, Saletti V, D\u2019Arrigo S, Esposito S, Alfei E, Moroni I, et al. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet. 2019;62:103596.","journal-title":"Eur J Med Genet"},{"key":"2863_CR113","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","volume":"33","author":"C Joinson","year":"2003","unstructured":"Joinson C, O\u2019Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003;33:335\u201344.","journal-title":"Psychol Med"},{"key":"2863_CR114","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:16035.","journal-title":"Nat Rev Dis Primers"},{"key":"2863_CR115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","volume":"76","author":"AL Numis","year":"2011","unstructured":"Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology. 2011;76:981\u20137.","journal-title":"Neurology"},{"key":"2863_CR116","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijdevneu.2011.01.003","volume":"29","author":"JD Cohen","year":"2011","unstructured":"Cohen JD, Nichols T, Brignone L, Hall SS, Reiss AL. Insular volume reduction in fragile X syndrome. Int J Dev Neurosci. 2011;29:489\u201394.","journal-title":"Int J Dev Neurosci"},{"key":"2863_CR117","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.21243","volume":"63","author":"D Gothelf","year":"2008","unstructured":"Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O\u2019Hara R, et al. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol. 2008;63:40\u201351.","journal-title":"Ann Neurol"},{"key":"2863_CR118","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuroimage.2006.09.043","volume":"34","author":"AD Lee","year":"2007","unstructured":"Lee AD, Leow AD, Lu A, Reiss AL, Hall S, Chiang MC, et al. 3D pattern of brain abnormalities in Fragile X syndrome visualized using tensor-based morphometry. Neuroimage. 2007;34:924\u201338.","journal-title":"Neuroimage"},{"key":"2863_CR119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpn.2020.07.003","volume":"28","author":"E Baudou","year":"2020","unstructured":"Baudou E, Nemmi F, Biotteau M, Maziero S, Assaiante C, Cignetti F, et al. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children? Eur J Paediatr Neurol. 2020;28:89\u2013100.","journal-title":"Eur J Paediatr Neurol"},{"key":"2863_CR120","doi-asserted-by":"crossref","first-page":"e47854","DOI":"10.1371\/journal.pone.0047854","volume":"7","author":"KH Karlsgodt","year":"2012","unstructured":"Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon TD, Silva A, Bearden CE. Alterations in white matter microstructure in neurofibromatosis-1. PLoS ONE. 2012;7:e47854.","journal-title":"PLoS ONE"},{"key":"2863_CR121","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1212\/WNL.54.4.914","volume":"54","author":"BD Moore 3rd","year":"2000","unstructured":"Moore BD 3rd, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology. 2000;54:914\u201320.","journal-title":"Neurology"},{"key":"2863_CR122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1866-1955-5-3","volume":"5","author":"IR Violante","year":"2013","unstructured":"Violante IR, Ribeiro MJ, Silva ED, Castelo-Branco M. Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: An uneven profile of developmental abnormalities. J Neurodev Disord. 2013;5:3.","journal-title":"J Neurodev Disord"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02863-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T18:30:29Z","timestamp":1742322629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02863-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02863-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}